Drugs / GD-iExo-003
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06810869 | Feb 2025 → Nov 2026 expected | vitiligo | Second Affiliated Hospital of Wannan Medical College | Not yet recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06138210 | Jun 2024 → Mar 2026 overdue | ischemic stroke | Xuanwu Hospital, Beijing | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GD-iExo-003 | “The Effect of GD-iExo-003 in Acute Ischemic Stroke” NCT06138210 ↗ |
| Modality | Other / unclassified | “induced pluripotent stem cell-derived exosomes (iPSC-Exos)” NCT06810869 ↗ |
| Route | Intravenous | “intravenous exosomes derived from human induced pluripotent stem cell (GD-iExo-003)” NCT06138210 ↗ |